MedTrace Logo

Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure

NCT02837744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-03-11

Study results available
· View outcomes & findings →

Summary

To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients.

Conditions

  • Percutaneous Coronary Intervention
  • Angiography
  • Angioplasty

Interventions

DEVICE

Axiostat®

Axiostat Chitosan Hemostatic dressing belongs to an advanced class of wound dressing that stops bleeding within few minutes of application by providing an active mechanical barrier.

Sponsors & Collaborators

  • Axio Biosolutions Pvt. Ltd.

    lead OTHER

Principal Investigators

  • Milan Chag, Dr. · Care Institute of Medical Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837744 on ClinicalTrials.gov